Total Voting Rights
May 1, 2014 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"), in accordance
with the Financial Conduct Authority's (the "FCA") Disclosure and Transparency
Rule 5.6.1R, notifies the market of the following:
At close of business on April 30, 2014, the Company's issued ordinary share
capital comprised 589,014,068 ordinary shares of 5 pence each with voting
rights and a further 9,019,832 ordinary shares held in treasury.
Therefore the total number of voting rights in the Company is 589,014,068. This
is the figure which should be used by shareholders as the denominator for the
calculations by which they will determine if they are required to notify their
interest in, or a change to their interest in, the Company under the FCA's
Disclosure and Transparency Rules.
Deputy Company Secretary
For further information please contact:
Jeff Poulton firstname.lastname@example.org +1 781 482 0945
Eric Rojas email@example.com +1 781 482 0999
Sarah Elton-Farr firstname.lastname@example.org +44 1256 894157
Notes to editors
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty
medicines to meet significant unmet patient needs.
We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal and
Internal Medicine and we are developing treatments for symptomatic conditions
treated by specialist physicians in other targeted therapeutic areas.
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX